Cancer, Advanced Completed Phase 1 Trials for Ridaforolimus (DB06233)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01380184Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059)Treatment
NCT01295632Safety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)Treatment